脂质体,liposome
1)liposome[英]['lip?us?um][美]['l?p?,som, 'la?p?-]脂质体
1.Preparation of glutathione liposomes by pH-gradient method;pH梯度法制备谷胱甘肽脂质体
2.Optimization of Technical Conditions of Alprostadil Liposome;前列地尔脂质体制备工艺条件优化
3.Study on the preparation and quality control of beta-elemene liposome;β-榄香烯脂质体的制备方法及质量研究
英文短句/例句

1.Effect of Phospholipid Composition on Characteristics of Liposomes Containing Zedoary Turmeric Oil磷脂组成对莪术油脂质体性质的影响
2.Research and Development of NobilisideA Freeze-drying LiposomesNobiliside A冻干脂质体的研究
3.Liposomes/niosomes for Vaginal Drug Delivery;脂质体/类脂泡囊阴道给药系统的研究
4.Preparation of Immunoglobulin G Lipsomes from Milk Fat Globule Membrane Phospholipids乳脂肪球膜磷脂-免疫球蛋白G脂质体的制备
5.Table 2. The effects of lecithin phospholipid lipisomes on lipid metabolism in high lipid rabbits (±s , n=10, mmol/L).表2.卵磷脂脂质体对高脂血症兔脂蛋白代谢的影响.
6.Preparation of Silybum Marianum Gaertn Seed Oil Liposomes and Evaluation of the Quality水飞蓟油脂质体的制备及其质量评价
7.Study on technology of preparation and quality evaluation of cyclosporin liposome环孢素脂质体的制备工艺与质量评价
8.Formulation and quality evaluation of Boswellia carterii Birdwood volatile oil liposomes乳香挥发油脂质体的制备及质量评价
9.Preparation and characteristics of volatile oil of Atractylodes Macrocephala Koidz.liposome白术挥发油脂质体的制备及质量考察
10.Targeting therapy of liposomes should he well matched with the liposome behavior in vivo.脂质体的靶向治疗应用与脂质体的体内生物学行为相一致。
11.The Application of Coenzyme Q_(10) Nanoliposomes and Study on Coenzyme Q_(10) Proliposomes;辅酶Q_(10)纳米脂质体的应用及辅酶Q_(10)前体脂质体的研究
12.Comparison of permeation rates in vitro between indometacin ultradeformable nanoliposomes and general nanoliposomes吲哚美辛柔性纳米脂质体与普通纳米脂质体体外透皮速率的比较
13.Preparation and Targetibility of Antitumor Preliposomes Entrapping Arsenous Oxide Bearing Monoclonal Antibody;靶向抗癌药(砒霜)前体脂质体的研究
14.Preparation of Transfersomes and Liposomes Complexed with Combind Salvia Miltiorrhiza;丹参复方传递体及普通脂质体的研究
15.Preparation and In Vitro Release of Tilmicosin Liposomes替米考星脂质体的制备及其体外释放
16.Research progress of coated liposome as drug carrier包覆脂质体作为药物载体的研究进展
17.Determination of Phospholipid Content of Elemene Liposomes with Spectrophotometric Method分光光度法测定榄香烯脂质体磷脂含量
18.Determination of Encapsulation Efficiency of Liposomes Containing Total Alkaloids from Seed of Strychnos nux-vomica L.马钱子总生物碱复合磷脂脂质体包封率的测定
相关短句/例句

Liposomes脂质体
1.The progress on application of long circulation liposomes drugs in anti-tumour therapy;长循环脂质体在抗肿瘤药物中的应用进展
2.Preparation of Matrine Liposomes by Active Loading Method;主动载药法制备苦参碱脂质体的研究
3)lipofectamine脂质体
1.Effect of lipofectamine-mediated endostatin gene therapy on human endometriosis lesions in nude mice脂质体介导内皮抑素基因治疗对裸鼠人子宫内膜异位症的作用
2.Eight days after tumor inoculation,the tumor-bearing mice were divided into 3 groups and injected intra-tumorally with one of the following preparations: pcDNA3-IFN-γ/Lipofectamine,pcDNA3 /Lipofectamine,and PBS respectively.方法构建携带IFN γ基因的真核表达质粒pcDNA3 IFN γ ,以脂质体作载体 ,对荷大肠癌小鼠行瘤体内注射IFN γ基因 ,检测经基因治疗后小鼠体内IFN γ基因的表达、脾脏的细胞毒性T淋巴细胞 (cyto toxicTlymphoctye,CTL)活性、肿瘤的大小、肿瘤局部的淋巴细胞浸润情况及荷瘤小鼠的生存期。
3.Conclusion: CEA in the DC (pcDNA3-CEA +) c is successfully expressed with Lipofectamine.结论 :用脂质体能成功将人CEA真核表达质粒转入DCs并表
4)lipofectin脂质体
1.The modified method of Lipofectin mediated transfer to mammal cell;脂质体介导哺乳动物细胞转染的改良方法
2.An improved inoculation technique for inoculating recombinant baculovirus into silkworm, Bombyx mori, using lipofectin;应用脂质体介导技术改变重组杆状病毒感染方法
3.The Expression of Green Fluocescent Protein Gene Transfected the Bone Marrow Stromal Cells with Lipofectin;脂质体介导转染的绿色荧光蛋白基因在骨髓基质细胞内表达
5)Cationic liposome脂质体
1.Study on the transfection of primary human skeletal muscle cells with different cationic liposome;阳离子脂质体转染人类骨骼肌原代细胞的初步研究
2.Preparation and properties of folate receptor-targeted cationic liposomes;以叶酸受体为靶向的阳离子脂质体的制备与性质考察
3.Objective To find a high explore by efficient method of transfecting foreign DNA into NIH3T3 cells by cationic liposome.方法以绿色荧光蛋白(GFP)为报告基因,利用流式细胞仪比较三种脂质体转染效果,用不同的细胞融合度、脂质体浓度、脂质体与质粒的比例、转染时间优化转染条件。
6)galactosyl ceramide liposomes糖脂脂质体
延伸阅读

脂质体分子式:分子量:CAS号:性质:一种水不溶性的、极性磷脂质组成的双层碟状液晶分子,在水中可形成一个或数个同心的脂质双分子层。脂质体可包蔽水和水溶性药物,也可将脂溶性药物结合在双分子层的脂质部分。脂质体在结构上可分为单层脂质体(直径约25纳米)、多层脂质体(约100纳米)和大脂质体(约0.13微米左右)。其特点是可减少剂量、降低毒性,减轻变态反应,可延缓药物的释放,减少药物在体内消除程度,提高药物的治疗效果,改变药物在组织中的分布,增强药物的选择性作用。